Guidelines for the Clinical Application of Endomyocardial Biopsy and Pathological Examination in Cardiomyopathy
Cardiomyopathy is an important type of cardiovascular diseases.The definition and classification of cardiomyopathy are progressed rapidly due to the continuous understanding of the disease features.Endomyocardial biopsy and pathological examination play increasingly important roles in the diagnosis and treatment of cardiomyopathy,with a growing body of evidence-based research and advancements.However,a significant number of medical institutions still have insufficient understanding and operation ability in terms of endocardial myocardial biopsy and pathological diagnosis.In view of this,the Cardiomyopathy Specialty Alliance,National Center for Cardiovascular Diseases and Cardiovascular Precision Medicine Branch,China International Exchange and Promotive Association for Medical and Health Care have formulated the present "Guidelines for the Clinical Application of Endomyocardial Biopsy and Pathological Examination in Cardiomyopathy".The aim of present guideline is to enhance the standards of endomyocardial biopsy and pathological examination in the diagnosis and treatment of cardiomyopathy in China.